247
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Emerging Moxifloxacin Resistance in Pseudomonas aeruginosa Keratitis Isolates in South India

, , , , , , , , , , , & show all
Pages 155-158 | Received 26 Oct 2012, Accepted 10 Jan 2013, Published online: 10 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sumayya Ahmad, Michelle Lopez, Marwan Attala, Anat Galor, Natalie A. Stanciu, Darlene Miller, Leejee Suh, Thomas Albini, Victor L. Perez, Carol L. Karp, Janet L. Davis, Eduardo Alfonso, Richard K. Forster & Guillermo Amescua. (2019) Interventions and Outcomes in Patients with Infectious Pseudomonas scleritis: A 10-Year Perspective. Ocular Immunology and Inflammation 27:3, pages 499-506.
Read now
Dinesh Subedi, Ajay Kumar Vijay & Mark Willcox. (2018) Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective. Clinical and Experimental Optometry 101:2, pages 162-171.
Read now
Rachel A. F. Wozniak & James V. Aquavella. (2017) Antibiotics in ophthalmology practice. Expert Review of Ophthalmology 12:3, pages 243-250.
Read now
Lixia Lin, Weizhong Lan, Bingsheng Lou, Hongmin Ke, Yuanzhe Yang, Xiaofeng Lin & Lingyi Liang. (2017) Genus Distribution of Bacteria and Fungi Associated with Keratitis in a Large Eye Center Located in Southern China. Ophthalmic Epidemiology 24:2, pages 90-96.
Read now

Articles from other publishers (32)

Eric R. Chen & Rachel A. F. Wozniak. (2024) Reimagining the Past: A Future for Antibiotic Drug Discovery in Ophthalmology. Cornea 43:1, pages 1-5.
Crossref
Shalini Shah & Rachel A. F. Wozniak. (2023) Staphylococcus aureus and Pseudomonas aeruginosa infectious keratitis: key bacterial mechanisms that mediate pathogenesis and emerging therapeutics. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Louisa Lu, Alice Shen, Charles DeBoer, Vinit Mahajan, Charles Lin & Jennifer Rose-Nussbaumer. (2023) CASE REPORT: Multidrug-resistant Pseudomonas keratitis and sequential endophthalmitis treated with chlorhexidine and piperacillin-tazobactam. Journal of EuCornea 12:1.
Crossref
Stephen Tuft, Jennifer Evans, Iris Gordon, Astrid Leck, Neil Stone, Timothy Neal, David Macleod, Stephen Kaye & Matthew J Burton. (2023) Antimicrobial resistance in topical treatments for microbial keratitis: protocol for a systematic review and meta-analysis. BMJ Open 13:3, pages e069338.
Crossref
Rose Herbert, Mary Caddick, Tobi Somerville, Keri McLean, Shakeel Herwitker, Timothy Neal, Gabriela Czanner, Stephen Tuft & Stephen B Kaye. (2022) Potential new fluoroquinolone treatments for suspected bacterial keratitis. BMJ Open Ophthalmology 7:1, pages e001002.
Crossref
Stephen Tuft, Tobi F. Somerville, Ji-Peng Olivia Li, Timothy Neal, Surjo De, Malcolm J. Horsburgh, Joanne L. Fothergill, Daniel Foulkes & Stephen Kaye. (2022) Bacterial keratitis: identifying the areas of clinical uncertainty. Progress in Retinal and Eye Research 89, pages 101031.
Crossref
Jia A. Mei, William Johnson, Bailey Kinn, Emily Laskey, Lydia Nolin, Pratham Bhamare, Charlotte Stalker, Paul M. Dunman & Rachel A. F. Wozniak. (2022) Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates . Translational Vision Science & Technology 11:5, pages 26.
Crossref
Darren Shu Jeng Ting, Charlotte Shan Ho, Jessica Cairns, Ahmad Elsahn, Mouhamed Al-Aqaba, Tim Boswell, Dalia G Said & Harminder Singh Dua. (2021) 12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study. British Journal of Ophthalmology 105:3, pages 328-333.
Crossref
Gunjan Budhiraja, Manisha Acharya & Mukesh Kumar. (2021) Role of topical high concentration levofloxacin 1.5% in bacterial keratitis. Indian Journal of Ophthalmology - Case Reports 1:4, pages 643.
Crossref
Joshua S. Hewitt, Rachel A. Allbaugh, Danielle E. Kenne & Lionel Sebbag. (2020) Prevalence and Antibiotic Susceptibility of Bacterial Isolates From Dogs With Ulcerative Keratitis in Midwestern United States. Frontiers in Veterinary Science 7.
Crossref
Wesley Hebert, Antonio DiGiandomenico & Michael Zegans. (2020) Multifunctional Monoclonal Antibody Targeting Pseudomonas aeruginosa Keratitis in Mice. Vaccines 8:4, pages 638.
Crossref
Huiyuan Li, Xiao Wang, Xiaofei Zhao, Guanhua Li, Fengyan Pei, Han Zhang, Yang Tan & Feng Chen. (2020) Vacancy‐Induced Antibacterial Activity of XS 2– y Quantum Dots against Drug‐Resistant Bacteria for Treatment of Bacterial Keratitis . Small 16:42.
Crossref
Maggie R. Jinks, Eric J. Miller, Dubraska Diaz‐Campos, Dixie F. Mollenkopf, Georgina Newbold, Anne Gemensky‐Metzler & Heather L. Chandler. (2020) Using minimum inhibitory concentration values of common topical antibiotics to investigate emerging antibiotic resistance: A retrospective study of 134 dogs and 20 horses with ulcerative keratitis. Veterinary Ophthalmology 23:5, pages 806-813.
Crossref
Irmak Karaca, Ozlem Barut Selver, Melis Palamar, Sait Egrilmez, Sohret Aydemir & Ayse Yagci. (2020) Contact Lens–Associated Microbial Keratitis in a Tertiary Eye Care Center in Turkey. Eye & Contact Lens: Science & Clinical Practice 46:2, pages 110-115.
Crossref
Paulo J. M. Bispo, Lawson Ung, James Chodosh & Michael S. Gilmore. 2020. Foundations of Corneal Disease. Foundations of Corneal Disease 277 288 .
Lawson Ung, Paulo J.M. Bispo, Swapna S. Shanbhag, Michael S. Gilmore & James Chodosh. (2019) Authors' response: Povidone-Iodine for the Treatment of Microbial Keratitis. Survey of Ophthalmology 64:6, pages 892-893.
Crossref
Michaelle Chojnacki, Alesa Philbrick, Tyler Scherzi, Nicole Pecora, Paul M. Dunman & Rachel A. F. Wozniak. (2019) A Novel, Broad-Spectrum Antimicrobial Combination for the Treatment of Pseudomonas aeruginosa Corneal Infections. Antimicrobial Agents and Chemotherapy 63:10.
Crossref
Linda D. Hazlett, Sandamali A. Ekanayaka, Sharon A. McClellan & Rebecca Francis. (2019) Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa : In Vitro and In Vivo Studies . Investigative Opthalmology & Visual Science 60:8, pages 2978.
Crossref
Michaelle Chojnacki, Alesa Philbrick, Benjamin Wucher, Jordan N. Reed, Andrew Tomaras, Paul M. Dunman & Rachel A. F. Wozniak. (2019) Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections. Antimicrobial Agents and Chemotherapy 63:1.
Crossref
Amy Lin, Michelle K. Rhee, Esen K. Akpek, Guillermo Amescua, Marjan Farid, Francisco J. Garcia-Ferrer, Divya M. Varu, David C. Musch, Steven P. Dunn & Francis S. Mah. (2019) Bacterial Keratitis Preferred Practice Pattern®. Ophthalmology 126:1, pages P1-P55.
Crossref
V. Galvis, M.M. Parra, A. Tello, Y.A. Castellanos, P.A. Camacho, D. Villarreal & S.L.L. Salcedo. (2019) Antibiotic resistance profile in eye infections in a reference centre in Floridablanca, Colombia. Archivos de la Sociedad Española de Oftalmología (English Edition) 94:1, pages 4-11.
Crossref
V. Galvis, M.M. Parra, A. Tello, Y.A. Castellanos, P.A. Camacho, D. Villarreal & S.L.L. Salcedo. (2019) Perfil de resistencia antibiótica en infecciones oculares en un centro de referencia en Floridablanca, Colombia. Archivos de la Sociedad Española de Oftalmología 94:1, pages 4-11.
Crossref
Yu-Ting HsiaoPo-Chiung FangJiunn-Liang ChenShiuh-Liang Hsu, Tsai-Ling ChaoHun-Ju YuYu-Hsuan LaiYu-Ting HuangMing-Tse Kuo. (2018) Molecular Bioburden of the Lens Storage Case for Contact Lens–Related Keratitis. Cornea 37:12, pages 1542-1550.
Crossref
Oriel Spierer, Darlene Miller & Terrence P O’Brien. (2018) Comparative activity of antimicrobials against Pseudomonas aeruginosa , Achromobacter xylosoxidans and Stenotrophomonas maltophilia keratitis isolates . British Journal of Ophthalmology 102:5, pages 708-712.
Crossref
Marko Oydanich, Tanis C. Dingle, Camille L. Hamula, Claudia Ghisa & Penny Asbell. (2017) Retrospective report of antimicrobial susceptibility observed in bacterial pathogens isolated from ocular samples at Mount Sinai Hospital, 2010 to 2015. Antimicrobial Resistance & Infection Control 6:1.
Crossref
J. Jeukens, I. Kukavica-Ibrulj, J. G. Emond-Rheault, L. Freschi & R. C. Levesque. (2017) Comparative genomics of a drug-resistant Pseudomonas aeruginosa panel and the challenges of antimicrobial resistance prediction from genomes. FEMS Microbiology Letters 364:18.
Crossref
Catherine E. Oldenburg & Thomas M. Lietman. (2017) The Challenge of Controlling Infectious Keratitis. American Journal of Ophthalmology 176, pages xv-xvi.
Crossref
Eubee B. Koo & Kathryn Colby. 2017. Corneal Diseases in Children. Corneal Diseases in Children 13 38 .
Merle Fernandes, Divya Vira, Radhika Medikonda & Nagendra Kumar. (2015) Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome. Graefe's Archive for Clinical and Experimental Ophthalmology 254:2, pages 315-322.
Crossref
Jayesh Vazirani, Siva Wurity & Md Hasnat Ali. (2015) Multidrug-Resistant Pseudomonas aeruginosa Keratitis. Ophthalmology 122:10, pages 2110-2114.
Crossref
Elmer Y. Tu, Francis S. Mah & Jules Baum. 2015. Clinical Infectious Disease. Clinical Infectious Disease 88 96 .
Alex Lap-Ki Ng, Kelvin Kai-Wang To, Chile Chi-Lai Choi, Leonard Hsu Yuen, Suk-Ming Yim, Keith Shun-Kit Chan, Jimmy Shiu-Ming Lai & Ian Yat-Hin Wong. (2015) Predisposing Factors, Microbial Characteristics, and Clinical Outcome of Microbial Keratitis in a Tertiary Centre in Hong Kong: A 10-Year Experience. Journal of Ophthalmology 2015, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.